首页> 外国专利> ENERGETIC CANCER STEM CELLS (E-CSCS): A NEW HYPER-METABOLIC AND PROLIFERATIVE TUMOR CELL PHENOTYPE, DRIVEN BY MITOCHONDRIAL ENERGY

ENERGETIC CANCER STEM CELLS (E-CSCS): A NEW HYPER-METABOLIC AND PROLIFERATIVE TUMOR CELL PHENOTYPE, DRIVEN BY MITOCHONDRIAL ENERGY

机译:能量癌症干细胞(E-CSCs):一种新的超代谢和增殖性肿瘤细胞表型,由线粒体能量驱动

摘要

This disclosure describes the characteristics of the “energetic” cancer stem cell (e-CSC) phenotype. This distinct sub-population of cancer stem cells (CSCs) has a unique energetic profile compared to bulk CSCs, being more glycolytic, having higher mitochondrial mass and elevated oxidative metabolism. e-CSCs also show an increased capacity to undergo cell cycle progression, enhanced anchorage-independent growth, and ALDH-positivity. The e-CSC phenotype presents new targets for cancer therapeutics, and in particular the anti-oxidant response, mitochondrial energy production, and mitochondrial biogenesis of e-CSCs makes them highly susceptible to mitochondrial inhibitors that target e-CSC anti-oxidant response, mitochondrial energy production, and mitochondrial biogenesis. Gene products for e-CSCs are disclosed, as well as classes of mitochondrial inhibiting therapeutic agents. Also disclosed are methods for identifying and separating e-CSCs from bulk cell populations.
机译:本公开描述了“能量”癌症干细胞(E-CSC)表型的特征。 与大量CSCs相比,这种不同的癌症干细胞(CSC)具有独特的能量型材,具有更高的线粒体质量和氧化代谢升高。 E-CSCs还显示出增加细胞周期进展的能力,增强锚固无关的生长和ALDH-阳性。 E-CSC表型为癌症治疗剂提供了新的靶标,特别是E-CSCs的抗氧化剂反应,线粒体能量产生和线粒体生物发生使它们极易易受靶向E-CSC抗氧化剂反应的线粒体抑制剂线粒体的影响 能量生产和线粒体生物发生。 公开了E-CSCs的基因产物,以及线粒体抑制治疗剂的类别。 还公开了用于从散装细胞群中鉴定和分离E-CSC的方法。

著录项

  • 公开/公告号US2021254177A1

    专利类型

  • 公开/公告日2021-08-19

    原文格式PDF

  • 申请/专利权人 LUNELLA BIOTECH INC.;

    申请/专利号US201917254157

  • 申请日2019-06-19

  • 分类号C12Q1/6886;A61K31/03;A61K31/519;A61K45/06;

  • 国家 US

  • 入库时间 2022-08-24 20:41:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号